Orion Medical, founded in Cham, Switzerland in March 2022, is a manufacturing solutions provider for the medical devices industry. The company is closely linked to Orion Additive Manufacturing (Orion AM), an established manufacturer of 3D printing systems for high-performance polymers based in Berlin, Germany.
Ceryx Medical, a Cardiff-based healthtech start-up developing bioelectronic technology that can mimic nerve centres to control a range of autonomic or rhythmical processes in the human body, has raised £3.8m in seed funding.
Swedish medtech start-up Capitainer has closed a share issue of SEK34 million (US$3.38 million) to capitalise on growing interest in homesampling with its new qDBS dried blood spot testing system. The investment round, led by Sciety, brought in both existing and new industry specialist investors and several board members and the CEO.
Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, a leading provider of control systems for the world’s most complex machines, announced that Neutron Therapeutics’ nuBeam BNCT System, using Cosylab’s OncologyOne software, has reached a significant milestone in its clinical commissioning at Helsinki University Hospital […]
FUJIFILM Healthcare Europe has formed a partnership with the ‘Augmented Operating Room’ (BOpA) Innovation Chair to accelerate the development of digital technologies for surgery.
Thirona BV and Pulmonx Corporation have extended their long-running strategic partnership, developing and commercializing solutions that help clinicians diagnose and treat emphysema patients through the Pulmonx StratX Lung Analysis Platform. StratX is a cloud-based quantitative CT analysis service that supports Zephyr Endobronchial Valve patient selection and treatment targeting by providing information on emphysema destruction, fissure […]
As of 26 May 2022, new rules on in vitro diagnostic medical devices (IVDR) such as HIV tests, pregnancy tests or COVID-19 tests, are applicable across the European Union. The rules will better protect public health and patient safety in respect to these devices, bringing EU law in line with technological advances and progress in […]
Current guidelines used to plan salvage radiation treatments in patients with local recurrence of prostate cancer should be updated to take into consideration information derived from novel imaging modalities, such as PSMA PET, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting. The study showed that PSMA PET […]
A targeted radionuclide alpha therapy, 225Ac-DOTATATE, has been shown to have long-term anti-tumour effects in patients with advanced-stage gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Results from the Phase II study showed promising survival rates, high response rates and an acceptable toxicity profile, making 225Ac-DOTATATE a potential treatment option for patients who have exhausted other forms of therapy. […]
Novel radiopharmaceutical pair detects and treats melanoma; Study shows potential for broad application in solid tumours
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
